FTRE
HOLD / NEUTRALMeanRevComposite
56.90
Technical
86.10
Fundamental
47.10
Rank
—
Price
23.14
Hurst
0.39
As of
Oct 30, 2026
Daily
Fortrea Holdings Inc.
HealthcareBiotechnologyFortrea Holdings Inc. is a contract research organization that assists pharmaceutical, biotechnology, and medical device companies with the development and testing of new products. The company offers services spanning early-stage drug studies through post-market surveillance, including clinical trial design and execution, regulatory compliance support, data analysis, and real-world evidence collection. Headquartered in Durham, North Carolina, Fortrea serves clients globally across multiple stages of the product development lifecycle.
Market cap
$2.1B
P/E (trailing)
—
P/E (forward)
18.67
PEG ratio
0.34
Dividend yield
0.00%
Beta
1.91
52w range
8.55 – 26.16
Return on equity
-12.34%
Profit margin
-2.58%
Revenue growth
-1.40%
Earnings growth
—
Price history
1Y: 21.29 (+103.5%) · range 8.87–25.88
Cycle position
82/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 0 · NOT READY · exit proximity 35
Conviction
28/ 100 · maturity 43%
VScore.2233
Buildup.2643
EMA entry setup.320
Fundamentals.1947
Volume profile
POC
17.87
Price vs POC
+29.5%
Overhead supply
8%
Runway
open sky
Value area 15.63–21.16 · 8% of 120d volume overhead · clean runway
Get an AI analyst's read on this ticker.Open the AI analyst
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.967 | Oct 30, 2026 |
| trend-signal | 0.241 | Oct 22, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
CONFIRMForward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -1.15% | +2.31% | mature |
| 40d | +4.25% | +7.08% | mature |